These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 16877724

  • 1. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
    Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Hollenstein J, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.
    J Clin Oncol; 2006 Aug 01; 24(22):3576-82. PubMed ID: 16877724
    [Abstract] [Full Text] [Related]

  • 2. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
    Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.
    J Clin Oncol; 2005 Oct 01; 23(28):6890-8. PubMed ID: 16129845
    [Abstract] [Full Text] [Related]

  • 3. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
    Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, Brzezinski A.
    Climacteric; 2009 Oct 01; 12(5):404-9. PubMed ID: 19479488
    [Abstract] [Full Text] [Related]

  • 4. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
    Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJ, Gaarenstroom KN, van Dorst EB, van der Putten H, Boonstra H, Aaronson NK.
    J Clin Oncol; 2007 Jan 20; 25(3):301-7. PubMed ID: 17235045
    [Abstract] [Full Text] [Related]

  • 5. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
    Vermeulen RFM, Beurden MV, Kieffer JM, Bleiker EMA, Valdimarsdottir HB, Massuger LFAG, Mourits MJE, Gaarenstroom KN, van Dorst EBL, van der Putten HWHM, Aaronson NK.
    Eur J Cancer; 2017 Oct 20; 84():159-167. PubMed ID: 28818705
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
    Armstrong K, Schwartz JS, Randall T, Rubin SC, Weber B.
    J Clin Oncol; 2004 Mar 15; 22(6):1045-54. PubMed ID: 14981106
    [Abstract] [Full Text] [Related]

  • 7. The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT.
    Fentiman IS, Allen D, Wheeler M, Rymer J.
    Climacteric; 2006 Apr 15; 9(2):135-45. PubMed ID: 16698660
    [Abstract] [Full Text] [Related]

  • 8. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD, Women's Health in Lund Area (WHILA) Study.
    Menopause; 2000 Apr 15; 7(4):273-81. PubMed ID: 10914621
    [Abstract] [Full Text] [Related]

  • 9. Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review.
    Finch A, Narod SA.
    Maturitas; 2011 Nov 15; 70(3):261-5. PubMed ID: 21893388
    [Abstract] [Full Text] [Related]

  • 10. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I, Kealy R, Edwards R, Forbes J, Cuzick J.
    J Clin Oncol; 2006 Aug 20; 24(24):3991-6. PubMed ID: 16921052
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM, Rebbeck TR.
    Curr Opin Obstet Gynecol; 2007 Feb 20; 19(1):27-30. PubMed ID: 17218848
    [Abstract] [Full Text] [Related]

  • 12. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun 20; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

  • 13. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ, Boulet MJ.
    Obstet Gynecol; 1997 Aug 20; 90(2):269-77. PubMed ID: 9241307
    [Abstract] [Full Text] [Related]

  • 14. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
    Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA.
    Gynecol Oncol; 2011 Apr 20; 121(1):163-8. PubMed ID: 21216453
    [Abstract] [Full Text] [Related]

  • 15. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
    Gavaler JS.
    J Womens Health (Larchmt); 2003 Oct 20; 12(8):757-68. PubMed ID: 14588126
    [Abstract] [Full Text] [Related]

  • 16. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E, Mattsson LA, Milsom I.
    Acta Obstet Gynecol Scand; 2000 Apr 20; 79(4):286-92. PubMed ID: 10746844
    [Abstract] [Full Text] [Related]

  • 17. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S, Kaplan B, Yaphe J, Cohen O, Shumla V, Shapira G, Shofty I, Kitai E.
    Climacteric; 2003 Mar 20; 6(1):75-80. PubMed ID: 12725667
    [Abstract] [Full Text] [Related]

  • 18. Type of menopause, patterns of hormone therapy use, and hot flashes.
    Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA.
    Fertil Steril; 2006 May 20; 85(5):1432-40. PubMed ID: 16566933
    [Abstract] [Full Text] [Related]

  • 19. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 20. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF, Wild RA.
    Menopause; 2007 Jul 20; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.